Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition

Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition

Background: Besides the cancer itself, venous thromboembolism (VTE) is the leading cause of death in cancer patients receiving outpatient chemotherapy (CT). Data on VTE development and impact on treatment course and outcome in real-life NSCLC patients receiving immune check-point inhibitors (ICI) is...

Full description

Bibliographic Details
Main Authors: Birgitte Bjørnhart, Karin Holmskov Hansen, Trine Lembrecht Jørgensen, Jørn Herrstedt, Tine Schytte
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Thrombosis Update
Subjects:
Immune checkpoint inhibitors
Non-small cell lung cancer
Real-life patients
Venous thromboembolism
Khorana score
Online Access:http://www.sciencedirect.com/science/article/pii/S2666572721000250

Internet

http://www.sciencedirect.com/science/article/pii/S2666572721000250

Similar Items